Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies

Multipotent mesenchymal stromal cells (MSC) have been widely explored for cell-based therapy of immune-mediated, inflammatory, and degenerative diseases, due to their immunosuppressive, immunomodulatory, and regenerative potentials. Preclinical studies and clinical trials have demonstrated promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Noronha NC, Nádia de Cássia, Mizukami, Amanda, Caliári-Oliveira, Carolina, Cominal, Juçara Gastaldi, Rocha, José Lucas M., Covas, Dimas Tadeu, Swiech, Kamilla, Malmegrim, Kelen C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498654/
https://www.ncbi.nlm.nih.gov/pubmed/31046833
http://dx.doi.org/10.1186/s13287-019-1224-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498654/
https://www.ncbi.nlm.nih.gov/pubmed/31046833
http://dx.doi.org/10.1186/s13287-019-1224-y

Ejemplares similares